Related Experiment Video
Updated: Jun 25, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study
Ezio Faglia1, Giacomo Clerici, Jacques Clerissi
1Diabetology Center, Diabetic Foot Center, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Multimedica, Sesto San Giovanni, Milano, Italy.
Insights
Diabetic patients with critical limb ischemia (CLI) face high risks of amputation and death. Early intervention and specialized care can significantly reduce these adverse outcomes, improving long-term prognosis.
Area of Science:
- Vascular Surgery
- Diabetology
- Cardiology
Background:
- Critical limb ischemia (CLI) poses a significant threat to diabetic patients.
- Understanding the long-term prognosis is crucial for effective management.
Purpose of the Study:
- To evaluate the long-term prognosis of critical limb ischemia (CLI) in diabetic patients.
- To identify factors influencing mortality and amputation rates.
Main Methods:
- A cohort of 564 diabetic patients hospitalized for CLI between 1999 and 2003 was followed for a mean of 5.93 years.
- Peripheral angioplasty (PTA) and bypass graft (BPG) were performed as revascularization strategies.
- Outcomes including major amputations, restenosis, bypass failures, and mortality were recorded.
Main Results:
- Nearly 50% of patients died during the follow-up period.
- Major amputation rates varied by treatment: 8.2% for PTA, 21.1% for BPG, and 59.2% for no revascularization.
- Contralateral limb CLI occurred in 39.9% of patients, with 6.7% requiring major amputation.
Conclusions:
- Diabetic patients with CLI have a high risk of amputation and mortality.
- Coronary artery disease (CAD) is the leading cause of death.
- Impaired ejection fraction is a major independent prognostic factor in patients with a history of CAD.
Objective:
To evaluate the long-term prognosis of critical limb ischemia (CLI) in diabetic patients.
Research Design And Methods:
A total of 564 consecutive diabetic patients were hospitalized for CLI from January 1999 to December 2003; 554 were followed until December 2007.
Results:
The mean follow-up was 5.93 +/- 1.28 years. Peripheral angioplasty (PTA) was performed in 420 (74.5%) and bypass graft (BPG) in 117 (20.6%) patients. Neither PTA nor BPG were possible in 27 (4.9%) patients. Major amputations were performed in 74 (13.4%) patients: 34 (8.2%) in PTA, 24 (21.1%) in BPG, and 16 (59.2%) in a group that received no revascularization. Restenosis occurred in 94 patients, bypass failures in 36 patients, and recurrent ulcers in 71 patients. CLI was observed in the contralateral limb of 225 (39.9%) patients; of these, 15 (6.7%) required major amputations (rate in contralateral compared with initial limb, P = 0.007). At total of 276 (49.82%) patients died. The Cox model showed significant hazard ratios (HRs) for mortality with age (1.05 for 1 year [95% CI 1.03-1.07]), unfeasible revascularization (3.06 [1.40-6.70]), dialysis (3.00 [1.63-5.53]), cardiac disease history (1.37 [1.05-1.79]), and impaired ejection fraction (1.08 for 1% point [1.05-1.09]).
Conclusions:
Diabetic patients with CLI have high risks of amputation and death. In a dedicated diabetic foot center, the major amputation, ulcer recurrence, and major contralateral limb amputation rates were low. Coronary artery disease (CAD) is the leading cause of death, and in patients with CAD history the impaired ejection fraction is the major independent prognostic factor.
Related Concept Videos
Diabetic Foot Ulcer
Diabetic Retinopathy
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease III: Interprofessional Care